Format

Send to

Choose Destination
J Investig Allergol Clin Immunol. 2019 Feb;29(1):79-81. doi: 10.18176/jiaci.0340.

Severe Eosinophilic Allergic Asthma Responsive to Mepolizumab After Failure of 2 Consecutive Biologics.

Author information

1
Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
2
CIBER de Enfermedades Respiratorias, Ciberes, Madrid, Spain.
3
Department of Pneumology, Hospital La Paz, Madrid, Spain.

KEYWORDS:

Anti-IL-5 antibodies; Biologics; Biomarkers; Phenotypes; Severe eosinophilic asthma

PMID:
30785114
DOI:
10.18176/jiaci.0340
Free full text

Supplemental Content

Full text links

Icon for Esmon Publicidad
Loading ...
Support Center